申请人:Beecham Group Limited
公开号:US04382094A1
公开(公告)日:1983-05-03
A compound of the formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein: Ar is phenyl, optionally substituted by one or more C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, cyano, nitro, hydroxy, CONH.sub.2, CO.sub.2 W wherein W is C.sub.1-6 alkyl or C.sub.1-4 alkylphenyl which phenyl may be substituted by one or more C.sub.1-4 alkyl, C.sub.1-4 alkoxy or halogen, NR.sub.1 R.sub.2 wherein R.sub.1 and R.sub.2 are selected from hydrogen or C.sub.1-6 alkyl, NHCO C.sub.1-6 alkyl or C.sub.1-6 alkylcarbonyloxy; phenyl disubstituted on adjacent carbon atoms by methylenedioxy; furyl or thienyl; the dotted lines represent an optionally present double bond; and X is CO or CR.sub.1 OH wherein R.sub.1 is hydrogen or C.sub.1-4 alkyl, having useful pharmacological activity, processes for their preparation and their use.
化合物的公式(I)及其药学上可接受的盐:##STR1##其中:Ar是苯基,可以选择性地用一个或多个C.sub.1-4烷基,C.sub.1-4烷氧基,卤素,氰基,硝基,羟基,CONH.sub.2,CO.sub.2W(其中W是C.sub.1-6烷基或C.sub.1-4烷基苯基,该苯基可以被一个或多个C.sub.1-4烷基,C.sub.1-4烷氧基或卤素所替代),NR.sub.1R.sub.2(其中R.sub.1和R.sub.2被选择为氢或C.sub.1-6烷基),NHCO C.sub.1-6烷基或C.sub.1-6烷基羧酸酯; 二邻甲氧基取代的苯基; 呋喃基或噻吩基; 点线表示可选的双键; X是CO或CR.sub.1OH,其中R.sub.1是氢或C.sub.1-4烷基,具有有用的药理活性,其制备方法及其用途。